Teva Pharmaceutical has proposed to acquire drug maker Mylan for about $40 billion in cash and stock, a sign of the jockeying for dominance among generic drug makers.
WSJ.com: WSJ India, Wall Street Journal: World: India
Tue, 04/21/2015 - 6:39am
Teva Pharmaceutical has proposed to acquire drug maker Mylan for about $40 billion in cash and stock, a sign of the jockeying for dominance among generic drug makers.